Arix Bioscience plc: Harpoon Announces Proposed Public Offering in the United States

December 28, 2018   |   December 2018 Bond Updates
Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation, today notes that its portfolio company Harpoon Therapeutics, Inc. ("Harpoon") has filed a registration statement on Form S-1 with the U.S. Securities and Exchange...

View more at:
Related News
Home| About us | Contact us